Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Bevacizumab in Never-Smokers with Advanced NSCLC
NCT00445848Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 2007
- Primary completion
- Aug 2013
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib, bevacizumab in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Started Jul 2007; status: completed.
02
Drugs
erlotinibbevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00445848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445848.